Molecular and Cell Physiology, Medical School Hanover, Germany.
Cardiol J. 2010;17(5):518-22.
In familial hypertrophic cardiomyopathy (FHC), asymmetric left ventricular (LV) hypertrophy has been considered to be the predominant phenotypic expression, whereas right ventricular (RV) involvement is still ambiguous. In most cases, the right ventricle remains unaffected until secondary pulmonary hypertension develops. Several FHC-causing mutations of genes encoding sarcomere-related proteins have been identified which are transmitted in an autosomal-dominant manner.
We report the case of a 61 year old member of a Catalan family with a Arg723Gly missense mutation of the β-myosin heavy chain (β-MHC), that is associated with a malignant phenotype characterized by sudden cardiac death and heart failure. Because of progressive systolic LV dysfunction, the patient received a heart transplant in 2003.
Molecular analysis of the myocardial tissue of the explanted heart, taken from the left and right ventricle, showed a similar deviation of the ratio of mutant vs wild type mRNA of the β-MHC of 71.8 ± 5% and 68.5 ± 3%, respectively. This finding was confirmed for LV biopsies of this patient on protein level, showing a similar proportion of mutated β-myosin. But since the patient is heterozygous for the β-MHC mutation and the mutation is located in a coding region, the relative increase of the expression of the mutant allele is unexpected. It has been demonstrated before by our group for several β-MHC mutations that the relative abundance of mutated mRNA/protein correlates with the clinical severity of the disease. But since the right ventricle shows no (or only minor) manifestation in terms of hypertrophy or dysfunction, the level of mRNA and protein expression is not the only factor responsible for the development of the phenotype of FHC.
Several mechanisms through which cardiac stresses may incite maladaptive cardiac remodeling primarily of the left ventricle that result in myocardial hypertrophy and heart failure are proposed. One of those triggers could be the enhanced work load of the left ventricle, especially if a LV outflow tract gradient is present, in contrast to the lesser demands to the right ventricle which is adapted to the low pressure system of the pulmonary circulation. Further studies are needed to confirm the results of this case, as well as functional studies involving both ventricles.
在家族性肥厚型心肌病(FHC)中,不对称性左心室(LV)肥厚被认为是主要的表型表达,而右心室(RV)受累仍然不明确。在大多数情况下,右心室在继发肺动脉高压发展之前保持不受影响。已经鉴定出几种编码肌节相关蛋白的 FHC 致病基因突变,这些突变以常染色体显性方式遗传。
我们报告了一个 61 岁的加泰罗尼亚家族成员的病例,该家族成员携带β-肌球蛋白重链(β-MHC)的 Arg723Gly 错义突变,该突变与恶性表型相关,特征为心脏性猝死和心力衰竭。由于进行性收缩性 LV 功能障碍,该患者于 2003 年接受了心脏移植。
对来自左心室和右心室的移植心脏心肌组织的分子分析显示,β-MHC 突变型与野生型 mRNA 的比率分别为 71.8±5%和 68.5±3%,存在类似的偏差。这一发现在该患者的 LV 活检中得到了证实,显示出类似比例的突变β-肌球蛋白。但是,由于该患者为β-MHC 突变的杂合子,且突变位于编码区,因此突变等位基因表达的相对增加是出乎意料的。我们之前的研究小组已经证明,对于几种β-MHC 突变,突变 mRNA/蛋白的相对丰度与疾病的临床严重程度相关。但是,由于右心室在肥厚或功能方面没有(或只有轻微)表现,因此 mRNA 和蛋白表达水平不是导致 FHC 表型发展的唯一因素。
提出了几种机制,通过这些机制,心脏压力可能会引发适应性不良的心脏重塑,主要是左心室的重塑,导致心肌肥厚和心力衰竭。其中一个触发因素可能是左心室的工作量增加,特别是如果存在左心室流出道梯度,而右心室的需求较小,因为右心室适应肺动脉循环的低压系统。需要进一步的研究来证实这个病例的结果,以及涉及左右心室的功能研究。